Showing results (161-170 of 288) with videos related to
Sort By:
Pageof 29
Haematologica|November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killingYael Morgenstern, JongBok Lee, Yoosu Na, et al.Leukemia Research|January 18, 2006
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997Larry D Cripe, Kevin Rader, Martin S Tallman, et al.Blood|May 21, 2013
Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Kim De Keersmaecker, et al.Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndromeYishai Ofran, Kalman Filanovsky, Anat Gafter-Gvili, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemiasDejan Juric, Norman J Lacayo, Meghan C Ramsey, et al.Blood|October 5, 2006
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.Blood|June 10, 2011
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acidJae H Park, Baozhen Qiao, Katherine S Panageas, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remissionJennifer L Holter Chakrabarty, Morel Rubinger, Jennifer Le-Rademacher, et al.Blood|August 19, 2010
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Larry D Cripe, Hajime Uno, Elisabeth M Paietta, et al.Blood|March 27, 2004
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemiasElisabeth Paietta, Adolfo A Ferrando, Donna Neuberg, et al.Pageof 29